Changes in food cravings, dietary quality, body composition, and dietary intake during GLP-1 receptor agonist therapy: The CRAVE study. // Obesity Pillars. – URL: https://www.sciencedirect.com/science/article/pii/S2667368126000483?dgcid=rss_sd_all
Changes in food cravings, dietary quality, body composition, and dietary intake during GLP-1 receptor agonist therapy: The CRAVE study. Obesity Pillars. https://www.sciencedirect.com/science/article/pii/S2667368126000483?dgcid=rss_sd_all
“Changes in food cravings, dietary quality, body composition, and dietary intake during GLP-1 receptor agonist therapy: The CRAVE study.” Obesity Pillars.
@article{article108379,
title = {Changes in food cravings, dietary quality, body composition, and dietary intake during GLP-1 receptor agonist therapy: The CRAVE study},
journal = {Obesity Pillars},
url = {https://www.sciencedirect.com/science/article/pii/S2667368126000483?dgcid=rss_sd_all}
}